(Q30815162)

26 June 2017

title

Lymphocyte data in Epstein-Barr-virus induced post-transplant lymphoproliferative disorder treated by rituximab (English)

1 reference

post-transplant lymphoproliferative disorder

26 June 2017

main subject

0 references

1 reference

5

Martine Munzer

1 reference

26 June 2017

1

Natacha Entz-Werle

1 reference

26 June 2017

Nadine Cojean

2

1 reference

26 June 2017

Audrey Barats

3

1 reference

26 June 2017

Didier Eyer

4

1 reference

26 June 2017

Béatrice Uring-Lambert

6

1 reference

26 June 2017

Annie Falkenrodt

7

1 reference

26 June 2017

Annie Babin

8

1 reference

26 June 2017

Patrick Lutz

9

1 reference

26 June 2017

publication date

1 August 2003

1 reference

Pediatric Transplantation

26 June 2017

published in

1 reference

26 June 2017

volume

7

1 reference

26 June 2017

issue

4

1 reference

26 June 2017

page(s)

277-281

1 reference

The importance of exogenous antigen in priming the human CD8+ T cell response: lessons from the EBV nuclear antigen EBNA1.

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

Early diagnosis of adenovirus infection and treatment with cidofovir after bone marrow transplantation in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Anti-CD20 monoclonal antibody for post-transplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Successful treatment of an Epstein-Barr virus-associated B-cell lymphoproliferative disease in a child with acute lymphoblastic leukemia using an anti-CD20 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

The Epstein-Barr virus and post-transplant lymphoproliferative disease: interplay of immunosuppression, EBV, and the immune system in disease pathogenesis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Pre-transplant immunological profile and risk factor analysis of post-transplant lymphoproliferative disease development: the results of a nested matched case-control study. The University of Pittsburgh PTLD Study Group

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Epstein-barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

CD4+ T-cell effectors inhibit Epstein-Barr virus-induced B-cell proliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

Successful treatment with rituximab of lymphoproliferative disorder in a child after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-3046.2003.00091.X

7 January 2021

10.1034/J.1399-3046.2003.00091.X

Identifiers

DOI

1 reference

release_5qvwoepvl5hxfesjl55p7hbe4u

26 June 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5qvwoepvl5hxfesjl55p7hbe4u

24 November 2022

mapped directly with Wikidata item

1 reference